- Q1 2024 Biogen Inc Earnings Call TranscriptApr 24, 2024$201.99 (+4.56%)Earnings
- Q4 2023 Biogen Inc Earnings Call TranscriptFeb 13, 2024$226.65 (-7.39%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Biogen Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Q3 2023 Biogen Inc Earnings Call TranscriptNov 08, 2023$231.69 (-5.67%)Earnings
- Biogen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Biogen Inc to Acquire Reata Pharmaceuticals Inc Call TranscriptJul 28, 2023
- Q2 2023 Biogen Inc Earnings Call TranscriptJul 25, 2023$270.31 (-2.42%)Earnings
- Q1 2023 Biogen Inc Earnings Call TranscriptApr 25, 2023$282.41 (-3.62%)Earnings
- Biogen Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Biogen Inc at Cowen Health Care Conference TranscriptMar 06, 2023
- Q4 2022 Biogen Inc Earnings Call TranscriptFeb 15, 2023$278.98 (-3.49%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- SAGE Therapeutics Inc and Biogen Inc to Discuss Potential Commercialization Plans for Zuranolone TranscriptDec 06, 2022
- Biogen Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Q3 2022 Biogen Inc Earnings Call TranscriptOct 25, 2022$273.56 (-0.39%)Earnings
- Biogen Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Biogen Inc Earnings Call TranscriptJul 20, 2022$207.49 (-5.80%)Earnings
- Q1 2022 Biogen Inc Earnings Call TranscriptMay 03, 2022$205.7 (-0.78%)Earnings
- Biogen Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Biogen Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Biogen Inc Earnings Call TranscriptFeb 03, 2022$220.17 (-2.13%)Earnings
- Biogen Inc Analyst Q&A Call TranscriptJan 13, 2022
- Biogen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Biogen Inc Engage and Emerge Trials at CTAD Call TranscriptNov 11, 2021
- Q3 2021 Biogen Inc Earnings Call TranscriptOct 20, 2021$266.57 (-0.58%)Earnings
- Biogen Inc to Present at the American Neurological Association Virtual Meeting TranscriptOct 17, 2021
- Biogen Inc Investor Day TranscriptSep 21, 2021
- Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Biogen Inc Earnings Call TranscriptJul 22, 2021$326.36 (+1.05%)Earnings
- Biogen Inc at SVB Leerink CNS Forum (Virtual) TranscriptJun 29, 2021
- Biogen Inc to Discuss the Approval of ADUHELM Call TranscriptJun 08, 2021
- Biogen Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Q1 2021 Biogen Inc Earnings Call TranscriptApr 22, 2021$259 (-4.02%)Earnings
- Biogen Inc at the Stifel 3rd Annual CNS Day TranscriptMar 31, 2021
- Biogen Inc Evaluation of aducanumab safety in early Alzheimer's disease at AD/PD TranscriptMar 13, 2021
- Biogen Inc Evaluation Of Aducanumab Efficacy And Safety In Early Alzheimer's Disease Discussion at AD/PD Conference Call TranscriptMar 13, 2021
- Biogen Inc Live Discussion of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD TranscriptMar 10, 2021
- Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD TranscriptMar 10, 2021
- Biogen Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Biogen Inc Aducanumab Webinar Update TranscriptFeb 23, 2021
- Q4 2020 Biogen Inc Earnings Call TranscriptFeb 03, 2021$263.25 (-5.21%)Earnings
- Biogen Inc Corporate Call TranscriptJan 14, 2021
- Biogen Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc TranscriptNov 30, 2020
- SAGE Therapeutics Inc Conference Call to Discuss Collaboration with Biogen Inc TranscriptNov 30, 2020
- Biogen Inc Aducanumab EMBARK study design and Q&A at CTAD 2020 TranscriptNov 04, 2020
- Q3 2020 Biogen Inc Earnings Call TranscriptOct 21, 2020$268.91 (+0.67%)Earnings
- Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP TranscriptSep 23, 2020
- Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Biogen Inc Aducanumab Phase 3 Topline Results at AAIC (encore presentation and Q&A) TranscriptJul 29, 2020
- Q2 2020 Biogen Inc Earnings Call TranscriptJul 22, 2020$280.81 (+0.22%)Earnings
- Biogen Inc at Leerink CybeRx Series CNS Forum TranscriptJun 23, 2020
- Biogen Inc Annual Shareholders Meeting TranscriptJun 03, 2020
- Biogen Inc to Discuss Aducanumab Phase 3 Topline Results at AAN Presentation TranscriptMay 18, 2020
- Q1 2020 Biogen Inc Earnings Call TranscriptApr 22, 2020$298.01 (-9.42%)Earnings
- Biogen Inc Aducanumab Phase 3 Topline Results TranscriptApr 02, 2020
- Biogen Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Sangamo Therapeutics Inc Earnings and Collaboration Agreement with Biogen Inc Call TranscriptFeb 28, 2020
- Q4 2019 Biogen Inc Earnings Call TranscriptJan 30, 2020$277.53 (-1.77%)Earnings
- Biogen Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Biogen Inc Investor Q&A Call TranscriptDec 05, 2019
- Biogen Inc Aducanumab Phase 3 Topline Results TranscriptDec 05, 2019
- Biogen Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- Q3 2019 Biogen Inc Earnings and Update on Aducanumab Call TranscriptOct 22, 2019
- Biogen Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Biogen Inc Earnings Call TranscriptJul 23, 2019$243.88 (+4.90%)Earnings
- Biogen Inc Annual Shareholders Meeting TranscriptJun 19, 2019
- Biogen Inc Webcast on ALS Portfolio Corporate Call TranscriptJun 05, 2019
- Biogen Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptMay 30, 2019
- Q1 2019 Biogen Inc Earnings Call TranscriptApr 24, 2019$224.4 (-2.52%)Earnings
- Biogen Inc at Cowen Health Care Conference TranscriptMar 11, 2019
- Biogen Inc to Acquire Nightstar Therapeutics PLC to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology Call TranscriptMar 04, 2019
- Q4 2018 Biogen Inc Earnings Call TranscriptJan 29, 2019$334.48 (+1.35%)Earnings
Biogen Inc Investor Day Transcript
Good morning, everyone. Thank you for joining us for our Investor R&D Day. I'm Mike Hencke in Investor Relations.
Before we begin, I would like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties. I encourage you to consult the risk factors in our SEC filings for additional detail.
We're excited to share with you today the progress we are making in R&D across neuroscience. Today's program will include multiple live presentations followed by a live Q&A session. The slides presented today can be found on the Investor section of our website.
We'll begin with presentations from our Chief Executive Officer, Michel Vounatsos; and Al Sandrock, our Head of R&D. You will then hear from a number of other senior leaders across therapeutic areas. And we will conclude with the Q&A session. We will take a short break at approximately 11:30 a.m. And we aim to conclude today's event at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)